192 related articles for article (PubMed ID: 16455109)
21. Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions.
Tran VH; Marks D; Duke RK; Bebawy M; Duke CC; Roufogalis BD
Nutr Cancer; 2011; 63(3):435-43. PubMed ID: 21462089
[TBL] [Abstract][Full Text] [Related]
22. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
23. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
24. Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters.
Weiss J; Sauer A; Divac N; Herzog M; Schwedhelm E; Böger RH; Haefeli WE; Benndorf RA
Biopharm Drug Dispos; 2010 Mar; 31(2-3):150-61. PubMed ID: 20222053
[TBL] [Abstract][Full Text] [Related]
25. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
27. Effect of dietary flavonoids on pathways involved in drug metabolism.
Cermak R
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):17-35. PubMed ID: 18370856
[TBL] [Abstract][Full Text] [Related]
28. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance.
Imai Y; Tsukahara S; Asada S; Sugimoto Y
Cancer Res; 2004 Jun; 64(12):4346-52. PubMed ID: 15205350
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
[TBL] [Abstract][Full Text] [Related]
30. Chrysin blocks topotecan-induced apoptosis in Caco-2 cells in spite of inhibition of ABC-transporters.
Schumacher M; Hautzinger A; Rossmann A; Holzhauser S; Popovic D; Hertrampf A; Kuntz S; Boll M; Wenzel U
Biochem Pharmacol; 2010 Aug; 80(4):471-9. PubMed ID: 20457140
[TBL] [Abstract][Full Text] [Related]
31. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
An G; Gallegos J; Morris ME
Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
[TBL] [Abstract][Full Text] [Related]
32. Polyphenols and cholesterol efflux: is coffee the next red wine?
Burke MF; Khera AV; Rader DJ
Circ Res; 2010 Mar; 106(4):627-9. PubMed ID: 20203311
[No Abstract] [Full Text] [Related]
33. Interaction of the breast cancer resistance protein with plant polyphenols.
Cooray HC; Janvilisri T; van Veen HW; Hladky SB; Barrand MA
Biochem Biophys Res Commun; 2004 Apr; 317(1):269-75. PubMed ID: 15047179
[TBL] [Abstract][Full Text] [Related]
34. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
[TBL] [Abstract][Full Text] [Related]
35. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
Vaidya SS; Walsh SW; Gerk PM
Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
[TBL] [Abstract][Full Text] [Related]
36. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.
Kerb R; Hoffmeyer S; Brinkmann U
Pharmacogenomics; 2001 Feb; 2(1):51-64. PubMed ID: 11258197
[TBL] [Abstract][Full Text] [Related]
37. Combined cereal and pulse flavonoids show enhanced bioavailability by downregulating phase II metabolism and ABC membrane transporter function in Caco-2 model.
Ravisankar S; Agah S; Kim H; Talcott S; Wu C; Awika J
Food Chem; 2019 May; 279():88-97. PubMed ID: 30611516
[TBL] [Abstract][Full Text] [Related]
38. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
[TBL] [Abstract][Full Text] [Related]
39. Assessment of dietary flavonoid intake among 50-year-old inhabitants of Wroclaw in 2008.
Ilow R; Regulska-Ilow B; Rózańska D; Misiewicz D; Grajeta H; Kowalisko A; Biernat J
Adv Clin Exp Med; 2012; 21(3):353-62. PubMed ID: 23214199
[TBL] [Abstract][Full Text] [Related]
40. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
Choudhuri S; Klaassen CD
Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
